Vanadium Compounds with Antidiabetic Potential
International Journal of Molecular Sciences · 27.10.2023 · 24 (21) · 15675
DOI: 10.3390/ijms242115675 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 27.10.2023. Verfasst von Luísa M P F Amaral und 3 weiteren Autor:innen. Beteiligte Einrichtung: LAQV, REQUIMTE, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do Porto, Rua do Campo Alegre, s/n, 40169-007 Porto, Portug…. Hauptthemen laut MEDLINE: Vanadium Compounds, Diabetes Mellitus. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 146 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e Tecnologia, Ministério da Ciência, Tecnologia e Ensino Superior, Stimulus of Scientific Employment 2018.
Abstract (Originalsprache)
Over the last four decades, vanadium compounds have been extensively studied as potential antidiabetic drugs. With the present review, we aim at presenting a general overview of the most promising compounds and the main results obtained with in vivo studies, reported from 1899–2023. The chemistry of vanadium is explored, discussing the importance of the structure and biochemistry of vanadate and the impact of its similarity with phosphate on the antidiabetic effect. The spectroscopic characterization of vanadium compounds is discussed, particularly magnetic resonance methodologies, emphasizing its relevance for understanding species activity, speciation, and interaction with biological membranes. Finally, the most relevant studies regarding the use of vanadium compounds to treat diabetes are summarized, considering both animal models and human clinical trials. An overview of the main hypotheses explaining the biological activity of these compounds is presented, particularly the most accepted pathway involving vanadium interaction with phosphatase and kinase enzymes involved in the insulin signaling cascade. From our point of view, the major discoveries regarding the pharmacological action of this family of compounds are not yet fully understood. Thus, we still believe that vanadium presents the potential to help in metabolic control and the clinical management of diabetes, either as an insulin-like drug or as an insulin adjuvant. We look forward to the next forty years of research in this field, aiming to discover a vanadium compound with the desired therapeutic properties.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- LAQV, REQUIMTE, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do Porto, Rua do Campo Alegre, s/n, 40169-007 Porto, Portugal.
- LAQV, REQUIMTE, Instituto de Ciências Biomédicas de Abel Salazar, Universidade do Porto, Rua de Jorge Viterbo Ferreira 228, 4050-313 Porto, Portugal.
ORCID-Profile: Luísa M P F Amaral, Tânia Moniz, André M N Silva, Maria Rangel
Förderung
- Fundação para a Ciência e Tecnologia
- Ministério da Ciência, Tecnologia e Ensino Superior
- Stimulus of Scientific Employment 2018
Zitieren
APA
Amaral, L. M. P. F., Moniz, T., Silva, A. M. N., & Rangel, M. (2023). Vanadium Compounds with Antidiabetic Potential. International Journal of Molecular Sciences, 24(21), 15675. https://doi.org/10.3390/ijms242115675
Vancouver
Amaral LMPF, Moniz T, Silva AMN, Rangel M. Vanadium Compounds with Antidiabetic Potential. International Journal of Molecular Sciences. 2023;24(21):15675. doi:10.3390/ijms242115675
BibTeX
@article{Amaral2023,
author = {Amaral, Luísa M P F and Moniz, Tânia and Silva, André M N and Rangel, Maria},
title = {Vanadium Compounds with Antidiabetic Potential},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {21},
pages = {15675},
doi = {10.3390/ijms242115675}
}
EUVIMED